SYM-2005

SYM-2005 is a preclinical medical device candidate being developed by Samyang Holdings Biopharm Group for applications in medical aesthetics. The product is based on self-assembled amphiphilic polymer technology, which utilizes molecules containing both hydrophilic and hydrophobic segments that spontaneously organize into stable nanostructures or hydrogels when placed in an aqueous environment. In the field of aesthetic medicine, these polymers are typically designed to serve as injectable fillers or scaffolds, providing immediate volume enhancement and structural support for tissue while ensuring biocompatibility and a controlled degradation profile.